Jeffs Roger's Form 4 filing
Axsome Therapeutics, Inc. (AXSM) · filed Aug 29, 2025
- Accession no.
- 0001231615-25-000006
- Filed
- Aug 29, 2025
- Trade date
- Aug 27-29, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $7.30M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Jeffs RogerCIK 0001231615 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 27, 2025 | Common Stock | SSaleDisposed | −20,000 | $122.30F3 | −$2,446,000 | 110,974 | Direct | |
| Aug 28, 2025 | Common Stock | SSaleDisposed | −20,000 | $121.60F4 | −$2,432,000 | 90,974 | Direct | |
| Aug 29, 2025 | Common Stock | SSaleDisposed | −20,000 | $121.27F5 | −$2,425,400 | 70,974 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $120.74 and $123.56.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $120.75 and $122.47.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $120.02 and $122.28.
Referenced by the price of 1 transaction in Table I.